4956 related articles for article (PubMed ID: 1642405)
1. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
Reintgen DS; Cox C; Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
[TBL] [Abstract][Full Text] [Related]
2. Age as a prognostic factor in the malignant melanoma population.
Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
[TBL] [Abstract][Full Text] [Related]
3. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
4. Etiology and prognosis of local recurrence in malignant melanoma of the skin.
Cruse CW; Wells KE; Schroer KR; Reintgen DS
Ann Plast Surg; 1992 Jan; 28(1):26-8. PubMed ID: 1642402
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prognostic considerations of head and neck melanoma.
Fisher SR; Seigler HF; George SL
Ann Plast Surg; 1992 Jan; 28(1):78-80. PubMed ID: 1642413
[TBL] [Abstract][Full Text] [Related]
6. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
7. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
8. Prognosis for recurrent stage I malignant melanoma.
Reintgen DS; Vollmer R; Tso CY; Seigler HF
Arch Surg; 1987 Nov; 122(11):1338-42. PubMed ID: 3675198
[TBL] [Abstract][Full Text] [Related]
9. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma of the skin: long-term follow-up and time to first recurrence.
Hohnheiser AM; Gefeller O; Göhl J; Schuler G; Hohenberger W; Merkel S
World J Surg; 2011 Mar; 35(3):580-9. PubMed ID: 21125274
[TBL] [Abstract][Full Text] [Related]
11. Relationship between disease-free interval and survival in patients with recurrent melanoma.
Crowley NJ; Seigler HF
Arch Surg; 1992 Nov; 127(11):1303-8. PubMed ID: 1444791
[TBL] [Abstract][Full Text] [Related]
12. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
13. Relapse patterns in patients with local and regional cutaneous melanoma.
Tas F; Erturk K
Clin Transl Oncol; 2019 Apr; 21(4):412-419. PubMed ID: 30182208
[TBL] [Abstract][Full Text] [Related]
14. Predicting survival and recurrence in localized melanoma: a multivariate approach.
Soong SJ; Shaw HM; Balch CM; McCarthy WH; Urist MM; Lee JY
World J Surg; 1992; 16(2):191-5. PubMed ID: 1561798
[TBL] [Abstract][Full Text] [Related]
15. Data on first recurrence after treatment for malignant melanoma in a large patient population.
Fusi S; Ariyan S; Sternlicht A
Plast Reconstr Surg; 1993 Jan; 91(1):94-8. PubMed ID: 8416544
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma in children.
Davidoff AM; Cirrincione C; Seigler HF
Ann Surg Oncol; 1994 Jul; 1(4):278-82. PubMed ID: 7850525
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of thick cutaneous melanoma of the trunk and extremity.
Coit D; Sauven P; Brennan M
Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
